HLA-B27已知时脊柱关节炎家族史对中轴型脊柱关节炎诊断的价值
该研究在ASAS、DESIR和SPACE三个独立队列共1818例疑似axSpA患者中,用logistic回归分析HLA-B27状态与ASAS定义的家族史对基线临床axSpA诊断的作用。结果显示HLA-B27在各队列均独立与axSpA诊断相关,而家族史(包括AS或急性前葡萄膜炎家族史)在校正HLA-B27后均无独立关联。提示在HLA-B27状态已知时,家族史对绝大多数背痛患者的axSpA诊断概率贡献有限。
要点
- HLA-B27在三队列中均独立与axSpA诊断相关(OR 6.9、2.1、10.4)。
- ASAS定义家族史在校正HLA-B27后与axSpA诊断无独立关联(OR 0.9、1.0、1.0)。
- AS或急性前葡萄膜炎家族史也呈类似阴性结果。
核心结论
- 在三个民族背景不同的独立队列中,家族史在HLA-B27之外并不独立与axSpA诊断相关。
- HLA-B27状态已知时,家族史对绝大多数背痛患者的axSpA诊断可能性无额外贡献。
研究设计与样本
- 基于ASAS(n=594)、DESIR(n=647)和SPACE(n=577)三个队列,共分析1818例疑似axSpA患者。
- 采用logistic回归,以HLA-B27状态和ASAS定义家族史为决定因素,基线临床axSpA诊断为结局。
- 另以AS或急性前葡萄膜炎家族史重复分析。
主要发现
- ASAS、DESIR、SPACE队列中ASAS-PFH比例分别为23%、39%、38%,HLA-B27阳性分别为52%、58%、43%,axSpA诊断分别为62%、47%、54%。
- HLA-B27与axSpA诊断独立相关:ASAS队列OR 6.9(95%CI 4.7,10.2),DESIR队列OR 2.1(95%CI 1.5,2.9),SPACE队列OR 10.4(95%CI 6.9,15.7)。
- ASAS-PFH与axSpA诊断无独立关联:ASAS队列OR 0.9(95%CI 0.6,1.4),DESIR队列OR 1.0(95%CI 0.7,1.3),SPACE队列OR 1.0(95%CI 0.7,1.5)。
- AS或急性前葡萄膜炎家族史亦呈类似阴性结果。
临床怎么用
- 对疑似axSpA的慢性背痛患者,若HLA-B27状态已知,家族史不宜作为独立增加诊断概率的依据。
- 问诊家族史仍可记录,但诊断决策应以HLA-B27状态及临床特征为主。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: A positive family history (PFH) of spondyloarthritis, in particular a PFH of AS or acute anterior uveitis, is associated with HLA-B27 carriership in chronic back pain patients. As it is unknown, the study aimed to investigate if a PFH contributes to diagnosing axial spondyloarthritis (axSpA) once HLA-B27 status is known. METHODS: In axSpA-suspected patients from the Assessment of SpondyloArthritis international Society (ASAS), DEvenir des Spondyloarthropathies Indifférenciéés Récentes (DESIR) and SPondyloArthritis Caught Early (SPACE) cohorts, logistic regression analyses were performed with HLA-B27 status and PFH according to the ASAS definition (ASAS-PFH) as determinants and clinical axSpA diagnosis as outcome at baseline. Analyses were repeated with a PFH of AS or acute anterior uveitis. RESULTS: In total, 1818 patients suspected of axSpA were analysed (ASAS n = 594, DESIR n = 647, and SPACE n = 577). In patients from the ASAS, DESIR and SPACE cohorts, respectively 23%, 39% and 38% had an ASAS-PFH, 52%, 58% and 43% were HLA-B27 positive, and 62%, 47% and 54% were diagnosed with axSpA. HLA-B27 was independently associated with an axSpA diagnosis in each cohort but an ASAS-PFH was not [ASAS cohort: HLA-B27 odds ratio (OR): 6.9 (95% CI: 4.7, 10.2), ASAS-PFH OR: 0.9 (95% CI: 0.6, 1.4); DESIR: HLA-B27 OR: 2.1 (95% CI: 1.5, 2.9), ASAS-PFH OR: 1.0 (95% CI 0.7, 1.3); SPACE: HLA-B27 OR: 10.4 (95% CI: 6.9, 15.7), ASAS-PFH OR: 1.0 (95% CI: 0.7, 1.5)]. Similar negative results were found for PFH of AS and acute anterior uveitis. CONCLUSION: In three independent cohorts with different ethnical backgrounds, ASAS, DESIR and SPACE, a PFH was not associated independently of HLA-B27 with a diagnosis of axSpA. This indicates that in the vast majority of patients presenting with back pain, a PFH does not contribute to the likelihood of an axSpA diagnosis if HLA-B27 status is known.
引用
- van Lunteren M, van der Heijde D, Sepriano A, et al. Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known? Rheumatology (Oxford). 2019. PMID: 30938446. doi:10.1093/rheumatology/kez095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。